DJIA 18,121.50 -81.87 -0.45%
NASDAQ 4,969.78 -10.13 -0.20%
S&P 500 2,100.67 -7.11 -0.34%
market minute promo

BioMarin Pharmaceuticals (NASDAQ: BMRN)

109.40 1.04 (0.96%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMRN $109.40 0.96%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $107.49
Previous Close $108.36
Daily Range $106.80 - $109.92
52-Week Range $55.04 - $111.89
Market Cap $17.4B
P/E Ratio -117.78
Dividend (Yield) $0.00 (0.0%)
Volume 462,211
Average Daily Volume 1,303,980
Current FY EPS -$2.14

Sector

Healthcare

Industry

Drug Makers

BioMarin Pharmaceuticals (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/

News & Commentary Rss Feed

Did Researchers Just Discover a Functional Cure for Duchenne Muscular Dystrophy?

Duchenne muscular dystrophy has no cure, and it often kills its victims by their mid-20s. However, a new international study lends hope that a functional cure to this disease could be in the offing.

First Trust Health Care AlphaDEX Fund Experiences Big Inflow

Company News for February 27, 2015 - Corporate Summary

Cowen Raises Price Targets on Top Momentum Stocks

Actavis' Infectious Disease Product, Avycaz, Gets FDA Nod - Analyst Blog

Amgen Reports Encouraging Late-Stage Data on AMG 416 - Analyst Blog

BioMarin Pharmaceutical's (BMRN) CEO JJ Bienaime on Q4 2014 Results - Earnings Call Transcript

"Profitability" in Sight for BioMarin Pharmaceutical Inc.

2017 could be the year for the orphan-drug maker.

After-Hours Earnings Report for February 25, 2015 : CRM, AVGO, LB, BMRN, CXO, AR, WDAY, MDVN, ESV,

After-Hours Earnings Report for February 25, 2015 : CRM, AVGO, LB, BMRN, CXO, AR, WDAY, MDVN, ESV, TEG, CSGP, MELI

What Evercore Is Watching At BioMarin Pharmaceutical

See More BMRN News...

BMRN's Top Competitors

BMRN $109.40 (0.96%)
Current stock: BMRN
AMGN $159.22 (0.42%)
Current stock: AMGN
GILD $103.97 (1.15%)
Current stock: GILD
BIIB $416.19 (0.82%)
Current stock: BIIB